Literature DB >> 10938609

Intrathecal baclofen alleviates autonomic dysfunction in severe brain injury.

R Becker1, L Benes, U Sure, D Hellwig, H Bertalanffy.   

Abstract

Sympathetic storm phenomena are well known therapeutic problems in patients with severe brain injury. We have treated four patients with intrathecal baclofen (ITB) who suffered from severe hypertension, tachycardia and other sympathetic storm phenomena after different primary events. In all patients conventional therapy with sedatives and antiadrenergic medication had been taken to the upper limits before initiating ITB. Autonomic dysfunction immediately improved in three of four patients. In all patients ITB, via lumbar or ventricular route, proved safe and without complications. The anatomical and pharmacological basis of the GABA-B agonist action on such sympathetic storm phenomena are not yet fully understood. However, the positive results observed in three out of four patients are promising and require further investigation. ITB is a new therapeutic approach to control otherwise unresponsive sympathetic storm phenomena in severe brain injury. Copyright 2000 Harcourt Publishers Ltd.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10938609     DOI: 10.1054/jocn.1999.0227

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


  17 in total

Review 1.  Imaging evaluation of intrathecal baclofen pump-catheter systems.

Authors:  A C Miracle; M A Fox; R N Ayyangar; A Vyas; S K Mukherji; D J Quint
Journal:  AJNR Am J Neuroradiol       Date:  2010-10-28       Impact factor: 3.825

2.  An investigation of the relationship between autonomic dysreflexia and intrathecal baclofen in patients with spinal cord injury.

Authors:  Anna Sophia Del Fabro; Melvin Mejia; Gregory Nemunaitis
Journal:  J Spinal Cord Med       Date:  2017-04-13       Impact factor: 1.985

3.  Evaluation of peripheral versus central effects of GABA(B) receptor activation using a novel, positive allosteric modulator of the GABA(B) receptor ADX71943, a pharmacological tool compound with a fully peripheral activity profile.

Authors:  M Kalinichev; T Donovan-Rodriguez; F Girard; E Riguet; M Rouillier; B Bournique; H Haddouk; V Mutel; S Poli
Journal:  Br J Pharmacol       Date:  2014-09-05       Impact factor: 8.739

4.  Paroxysmal autonomic instability with dystonia (PAID) syndrome following cardiac arrest.

Authors:  Dheeraj Kapoor; Deepak Singla; Jasveer Singh; Rohit Jindal
Journal:  Singapore Med J       Date:  2014-08       Impact factor: 1.858

Review 5.  Autonomic dysfunction in the neurological intensive care unit.

Authors:  Max J Hilz; Mao Liu; Sankanika Roy; Ruihao Wang
Journal:  Clin Auton Res       Date:  2018-07-18       Impact factor: 4.435

Review 6.  Autonomic dysfunction syndromes after acute brain injury.

Authors:  Courtney Takahashi; Holly E Hinson; Ian J Baguley
Journal:  Handb Clin Neurol       Date:  2015

7.  Gabapentin in the management of dysautonomia following severe traumatic brain injury: a case series.

Authors:  Ian J Baguley; Roxana E Heriseanu; Joseph A Gurka; Annette Nordenbo; Ian D Cameron
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-05       Impact factor: 10.154

Review 8.  Modulation of pain transmission by G-protein-coupled receptors.

Authors:  Hui-Lin Pan; Zi-Zhen Wu; Hong-Yi Zhou; Shao-Rui Chen; Hong-Mei Zhang; De-Pei Li
Journal:  Pharmacol Ther       Date:  2007-09-22       Impact factor: 12.310

Review 9.  A critical review of the pathophysiology of dysautonomia following traumatic brain injury.

Authors:  Ian J Baguley; Roxana E Heriseanu; Ian D Cameron; Melissa T Nott; Shameran Slewa-Younan
Journal:  Neurocrit Care       Date:  2008       Impact factor: 3.210

10.  Treatment of paroxysmal sympathetic hyperactivity.

Authors:  Alejandro A Rabinstein; Eduardo E Benarroch
Journal:  Curr Treat Options Neurol       Date:  2008-03       Impact factor: 3.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.